News Page

The Global Fund has recently announced that its priorities for multi-country investments over the 2017-2019 funding cycle do not include HIV programs in Africa. This decision will affect eight current grants worth nearly $60 million, many of which have had less than two years of implementation

A two-drug, long-acting injectable regimen of HIV medications has demonstrated efficacy in maintaining HIV-1 viral suppression throughout almost two years of treatment. The results come from the ongoing LATTE-2 trial and were presented today at the 9th International AIDS Society (IAS)...

Tablets made from dried leaves of the Artemisia annua plant cured 18 critically ill patients in a Congo clinic. The results suggest a new and inexpensive treatment option for the mosquito-borne disease that affects 212 million people worldwide.